"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about VALPROATE
• Ask Community about VALPROATE
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

VALPROATE Safety Questions, VALPROATE Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about VALPROATE. Our extensive database of VALPROATE adverse events and VALPROATE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about VALPROATE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

VALPROATE Safety Reports

Total VALPROATE reports: 129.
VALPROATE FDA safety alerts: 2002 .
Reported deaths: 35    Reported hospitalizations: 58.
Take VALPROATE Side Effects Survey or Share Your VALPROATE Story. Read More Here.

Showing 1-75 of 129 Next >

Consumer or non-health professional from GERMANY reported VALPROATE problem on Aug 18, 2006. Male patient, child 2. years of age, was diagnosed with grand mal convulsion, lennox-gastaut syndrome and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: coma, convulsion, grand mal convulsion, hepatic cirrhosis, hepatic steatosis, hepatocellular damage, hepatotoxicity, status epilepticus. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Health Professional from FRANCE on Oct 19, 2006. Male patient, 45 years of age, was diagnosed with alcoholic seizure and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: bedridden, communication disorder, confusional state, somnolence. VALPROATE dosage: unknown. During the same period patient was treated with PHENYTOIN, LEKOVIT CA, PROPRANOLOL, SENNA, RANITIDINE, THIAMINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported VALPROATE problem on Sept 29, 2004. Male patient, 36 years of age, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, fall, hyponatraemia, hypotension, pancytopenia, thrombocytopenia. VALPROATE dosage: unknown. During the same period patient was treated with RISPERIDONE, LEVETIRACETAM, CITALOPRAM, PROCYCLIDINE HYDROCHLORIDE, TEMAZEPAM. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on Mar 17, 2005. Male patient, 36 years of age, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: confusional state, pancytopenia. VALPROATE dosage: unknown. During the same period patient was treated with RISPERIDONE. Patient was hospitalized. Patient recovered.

Pharmacist from FRANCE reported VALPROATE problem on Oct 31, 2006. Male patient, 48 years of age, was diagnosed with epilepsy, analgesic effect, arthritis, abdominal discomfort and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: arthritis, impaired work ability, infection, mobility decreased. VALPROATE dosage: unknown. During the same period patient was treated with PHENOBARBITAL, ACETAMINOPHEN W, ACETAMINOPHEN W, DICLOFENAC, OMEPRAZOLE. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from NORWAY on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, status epilepticus. VALPROATE dosage: unknown. Patient died.

Consumer or non-health professional from NORWAY reported VALPROATE problem on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, status epilepticus. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 29, 2004. Male patient, 36 years of age, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, fall, hyponatraemia, hypotension, pancytopenia, thrombocytopenia. VALPROATE dosage: unknown. During the same period patient was treated with RISPERIDONE, LEVETIRACETAM, CITALOPRAM HYDROBROMIDE, PROCYCLIDINE HYDROCHLORIDE, TEMAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported VALPROATE problem on Nov 03, 2006. Male patient, 31 years of age, was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial, renal failure. VALPROATE dosage: unknown. During the same period patient was treated with LAMOTRIGINE. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on Sept 29, 2004. Male patient, 36 years of age, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, fall, hyponatraemia, hypotension, pancytopenia, thrombocytopenia. VALPROATE dosage: unknown. During the same period patient was treated with RISPERIDONE, LEVETIRACETAM, CITALOPRAM HYDROBROMIDE, PROCYCLIDINE HYDROCHLORIDE, TEMAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NORWAY reported VALPROATE problem on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, disseminated intravascular coagulation, hepatic failure, status epilepticus. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Consumer or non-health professional from NORWAY on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, disseminated intravascular coagulation, hepatic failure, status epilepticus. VALPROATE dosage: unknown. Patient died.

Consumer or non-health professional from NORWAY reported VALPROATE problem on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, disseminated intravascular coagulation, hepatic failure, status epilepticus. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Consumer or non-health professional from NORWAY on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, disseminated intravascular coagulation, hepatic failure, status epilepticus. VALPROATE dosage: unknown. Patient died.

Health Professional from UNITED KINGDOM reported VALPROATE problem on Nov 03, 2006. Female patient, 68 years of age, was diagnosed with epilepsy, hypertension and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. VALPROATE dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on Nov 16, 2006. Female patient, 51 years of age, was diagnosed with grand mal convulsion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, coma, diarrhoea, hepatic failure, hypotension, nausea, nosocomial infection, pneumonia, respiratory failure. VALPROATE dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported VALPROATE problem on Nov 16, 2006. Male patient, child 4 years of age, weighting 39.68 lb, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome. VALPROATE dosage: unknown. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from NORWAY on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, status epilepticus. VALPROATE dosage: unknown. Patient died.

Consumer or non-health professional from NORWAY reported VALPROATE problem on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: status epilepticus. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Consumer or non-health professional from NORWAY on Aug 08, 2006. Female patient, 19 years of age, was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, status epilepticus. VALPROATE dosage: unknown. Patient died.

Consumer or non-health professional from NORWAY reported VALPROATE problem on Aug 08, 2006. Female patient was diagnosed with epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, multi-organ failure, status epilepticus. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on Nov 29, 2006. Female patient, child 11 years of age, was diagnosed with impulsive behaviour and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: chorea, encephalopathy. VALPROATE dosage: unknown. During the same period patient was treated with RISPERDONE, ATOMOXETINE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported VALPROATE problem on Nov 02, 2005. Female patient, weighting 165.3 lb, was diagnosed with affective disorder, depression, delusion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. VALPROATE dosage: unknown. During the same period patient was treated with CIPRALEX FILM, CIPRALEX FILM, AMITRIPTYLINE HYDROCHLORIDE, OLANZAPINE. Patient recovered.

VALPROATE problem was reported by a Physician from GERMANY on Nov 02, 2005. Female patient, weighting 165.3 lb, was diagnosed with affective disorder, depression, delusion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. VALPROATE dosage: unknown. During the same period patient was treated with CIPRALEX FILM, CIPRALEX FILM, AMITRIPTYLINE HYDROCHLORIDE, OLANZAPINE. Patient recovered.

Physician from UNITED KINGDOM reported VALPROATE problem on Dec 12, 2006. Female patient was diagnosed with rectal cancer and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: epilepsy. VALPROATE dosage: unknown. During the same period patient was treated with ELOXATIN, OMEPRAZOLE. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on Dec 12, 2006. Male patient, child 8 years of age, was diagnosed with electroencephalogram abnormal, epilepsy and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, mental impairment. VALPROATE dosage: unknown. During the same period patient was treated with CLOBAZAM. Patient recovered.

Health Professional from FRANCE reported VALPROATE problem on Dec 21, 2006. Male patient, 72 years of age, was diagnosed with pain and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: feeling abnormal. VALPROATE dosage: unknown. During the same period patient was treated with TRAMADOL, ASPIRIN, ENALAPRIL MALEATE, OMEPRAZOLE. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from INDIA on Dec 20, 2006. Male patient, child 2 years of age, was diagnosed with febrile convulsion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. VALPROATE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported VALPROATE problem on July 04, 2007. Female patient was diagnosed with sleep disorder, accidental overdose and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal sleep-related event, accidental overdose, amnesia, road traffic accident. VALPROATE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Health Professional from FRANCE on July 11, 2007. Female patient, weighting 57.32 lb, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: astigmatism, body dysmorphic disorder, cheilitis, congenital eye disorder, coordination abnormal, croup infectious, disturbance in attention, dysmorphism. VALPROATE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE. Patient recovered.

Health Professional from FRANCE reported VALPROATE problem on July 11, 2007. Female patient, weighting 5.86 lb, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, asthma, developmental delay, dysmorphism, educational problem, expressive language disorder, eye disorder, foetal anticonvulsant syndrome, foot deformity. VALPROATE dosage: unknown. Patient recovered.

VALPROATE problem was reported by a Health Professional from AUSTRALIA on July 16, 2007. Female patient, weighting 154.3 lb, was diagnosed with affective disorder, sleep disorder, accidental overdose and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal sleep-related event, accidental overdose, amnesia, road traffic accident. VALPROATE dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported VALPROATE problem on July 19, 2007. Female patient, 41 years of age, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt. VALPROATE dosage: unknown. During the same period patient was treated with VENLAFAXIINE, OLANZAPINE. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Physician from FRANCE on July 26, 2007. Male patient, 34 years of age, was diagnosed with depression, affective disorder and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: convulsion. VALPROATE dosage: unknown. During the same period patient was treated with DOSULEPIN. Patient recovered.

Physician from FRANCE reported VALPROATE problem on July 26, 2007. Male patient, child 8 years of age, was diagnosed with convulsion, intracranial pressure increased, medulloblastoma and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, dyskinesia, muscle contractions involuntary, thrombocytopenia. VALPROATE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ACETAZOLAMIDE, VINCRISTINE, ETOPOSIDE, CARBOPLATIN. Patient recovered.

VALPROATE problem was reported by a Physician from FRANCE on Aug 02, 2007. Male patient, 34 years of age, was diagnosed with depression, affective disorder and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: convulsion. VALPROATE dosage: unknown. During the same period patient was treated with DOSULEPIN. Patient recovered.

Consumer or non-health professional from FRANCE reported VALPROATE problem on Aug 01, 2007. Male patient, 16 years of age, was diagnosed with epilepsy, autism, abnormal behaviour, sleep disorder and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral. VALPROATE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, RISPERIDONE, MELATONIN. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from CANADA on July 23, 2007. Female patient, 58 years of age, was diagnosed with bipolar disorder and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: convulsion, neck pain. VALPROATE dosage: 500 MG;BID; 500 MG;TAB;PO;BID; 1500 MG;TAB;PO;QD; 1000 MG;TAB;PO;QD. During the same period patient was treated with TEMAZEPAM, TRAZODONE, HYDROMORPHONE, LOSARTAN POTASSIUM, PROCYCLIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from TURKEY reported VALPROATE problem on Aug 07, 2007. Female patient, weighting 9.92 lb, was diagnosed with convulsion and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: brain oedema, hyperammonaemia, overdose. VALPROATE dosage: unknown. Patient died.

VALPROATE problem was reported by a Consumer or non-health professional from ITALY on Aug 16, 2007. Female patient, child 9. years of age, was diagnosed with convulsion, pneumonia and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: convulsion. VALPROATE dosage: 20 MG/KG/DAY. During the same period patient was treated with MEROPENEM. Patient recovered.

Health Professional from SINGAPORE reported VALPROATE problem on Aug 31, 2007. Male patient, 34 years of age, was diagnosed with schizophrenia and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, abdominal tenderness, blood creatinine increased, blood pressure decreased, blood urea increased, colectomy, constipation, dehydration. VALPROATE dosage: 400 MG, TID. During the same period patient was treated with BENZTROPINE MESYLATE, DIAZEPAM, CLOZAPINE. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from BELGIUM on Aug 28, 2007. Male patient, 16 years of age, was diagnosed with status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENYTOIN, PHENOBARBITAL, CLOBAZAM, TOPIRAMATE, LAMOTRIGINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported VALPROATE problem on Aug 28, 2007. Male patient, 15 years of age, was diagnosed with partial seizures, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, LORAZEPAM. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from BELGIUM on Aug 28, 2007. Male patient, 57 years of age, was diagnosed with status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENYTOIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported VALPROATE problem on Aug 28, 2007. Female patient, 23 years of age, was diagnosed with partial seizures, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENYTOIN, LEVETIRACETAM, MIDAZOLAM. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from BELGIUM on Aug 28, 2007. Female patient, 71 years of age, was diagnosed with myoclonic epilepsy, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENOBARBITAL, TOPIRAMATE, PROPOFOL, MIDAZOLAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported VALPROATE problem on Aug 28, 2007. Female patient, 43 years of age, was diagnosed with status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENYTOIN, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from BELGIUM on Aug 28, 2007. Female patient, 41 years of age, was diagnosed with status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENOBARBITAL, PHENYTOIN, PROPOFOL, MIDAZOLAM, LEVETIRACETAM, TOPIRAMATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported VALPROATE problem on Aug 28, 2007. Male patient, 46 years of age, was diagnosed with grand mal convulsion, status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from BELGIUM on Aug 28, 2007. Male patient, 74 years of age, was diagnosed with status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, CARBAMAZEPINE, LEVETIRACETAM, TOPIRAMATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported VALPROATE problem on Aug 28, 2007. Male patient, 43 years of age, was diagnosed with status epilepticus, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENOBARBITAL, TOPIRAMATE, LEVETIRACETAM, MIDAZOLAM, PROPOFOL. Patient was hospitalized. Patient recovered.

VALPROATE problem was reported by a Consumer or non-health professional from BELGIUM on Aug 28, 2007. Male patient, 71 years of age, was diagnosed with status epilepticus, simple partial seizures, infection and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal. VALPROATE dosage: unknown. During the same period patient was treated with MEROPENEM, PHENYTOIN, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported VALPROATE problem on Sept 06, 2007. Male patient, weighting 8.82 lb, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: amblyopia, autism spectrum disorder, congenital nose malformation, congenital oral malformation, dysmorphism, foetal anticonvulsant syndrome, head deformity, strabismus. VALPROATE dosage: unknown. During the same period patient was treated with FOLATE. Patient recovered.

VALPROATE problem was reported by a Physician from FRANCE on Sept 18, 2007. Male patient, child 8 years of age, was diagnosed with convulsion, intracranial pressure increased, medulloblastoma and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: dyskinesia, muscle contractions involuntary, thrombocytopenia. VALPROATE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ACETAZOLAMIDE, VINCRISTINE, ETOPOSIDE, CARBOPLATIN. Patient recovered.

Showing 1-75 of 129 Next >

Ask Our Patient Community about VALPROATE
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam) Protonix (pantoprazole) Protopic (tacrolimus) Provigil (modafinil) Prozac (fluoxetine) Prussian blue back to top	Q Quazepam Quetiapine Quinapril Quinupristin R Rabeprazole Radiogardase (prussian blue) Ramelteon Ramipril Ranexa (ranolazine) Ranibizumab Ranolazine Rapamune (sirolimus) Raptiva (efalizumab) Rasagiline Razadyne (galantamine) Rebetol (ribavirin) Reclast (zoledronic acid) Refludan (lepirudin recombinant) Relenza (zanamivir) Relpax (eletriptan) Remeron (mirtazapine) Renagel (sevelamer) Rescula (unoprostone isopropyl) Restoril (temazepam) Revatio (sildenafil) Revlimid (lenalidomide) Reyataz (atazanavir sulfate) Ribasphere (ribavarin ribasphere) Ribavarin ribasphere Rifapentine Rifaximin Risedronate Risperdal (risperidone) Risperidone Ritalin (methylphenidate) Ritonavir Rituxan Rituximab